University of Birmingham-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8013349)
◆英語タイトル:University of Birmingham - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013349
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:32
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
University of Birmingham is an academic research university that offers educational services. The university provides undergraduate, postgraduate, postgraduate research, and distance learning programs. It offers educational courses in various fields including accounting, astronomy, computer science, education and social justice, philosophy, natural sciences, metallurgy and materials, teacher education, drama and theatre arts, social policy, liberal arts and science, and others. University of Birmingham conducts research in the areas of arts and law, engineering and physical sciences, medical and dental sciences, life and environmental sciences, and social sciences. The university operates through various institutions for its researches. It also provides distance learning, professional development, and information for applicants. The university also operates through its various colleges and schools. University of Birmingham is headquartered in Birmingham, the UK.

University of Birmingham – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Birmingham, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Birmingham, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Birmingham, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Birmingham, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Birmingham, Medical Devices Deals, 2011 to YTD 2017 9
University of Birmingham, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Birmingham, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Faron Pharma Enters into Agreement with University of Birmingham Medical School 11
Cell Therapy Catapult Enters into Joint venture Agreement with University of Birmingham and Cancer Research Technology 12
University of Birmingham Enters Into Agreement With BGI Shenzhen And GigaScience 13
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 14
Beijing Genomics Institute Enters Into Agreement With University of Birmingham 15
University of Birmingham – Key Competitors 16
University of Birmingham – Key Employees 17
University of Birmingham – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 19
Recent Developments 20
Government and Public Interest 20
Nov 23, 2017: Children with heart disease are being let down by lack of clinical trials, study finds 20
Nov 02, 2017: Scientists awarded £1.5m for pioneering bowel cancer research 21
Aug 23, 2017: Scientists discover common obesity and diabetes drug reduces rise in brain pressure 22
Jul 17, 2017: Study Discovers Anticoagulant Drugs are being Prescribed against Safety Advice 23
Jul 14, 2017: University of Birmingham launches £2 million global research project 24
May 15, 2017: University of Birmingham develops revolutionary eye drops to treat age-related blindness 25
Feb 13, 2017: Gene discovery sheds light on growth defects linked to dwarfism 26
Nov 23, 2016: Fibroblasts could provide new target for treatment of rheumatoid arthritis 27
Jul 26, 2016: Finding the best treatment for prostate cancer 28
Jun 30, 2016: CANTAB Research Grant 2016 – Results 29
Apr 11, 2016: Shining new light on diabetes treatment 30
Product News 31
Nov 24, 2017: Experimental drug trial seeks to improve treatment for head and neck cancer 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
University of Birmingham, Pharmaceuticals & Healthcare, Key Facts 2
University of Birmingham, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Birmingham, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Birmingham, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Birmingham, Deals By Therapy Area, 2011 to YTD 2017 8
University of Birmingham, Medical Devices Deals, 2011 to YTD 2017 9
University of Birmingham, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Faron Pharma Enters into Agreement with University of Birmingham Medical School 11
Cell Therapy Catapult Enters into Joint venture Agreement with University of Birmingham and Cancer Research Technology 12
University of Birmingham Enters Into Agreement With BGI Shenzhen And GigaScience 13
Thermo Fisher Scientific Enters Into Research Agreement With University of Birmingham 14
Beijing Genomics Institute Enters Into Agreement With University of Birmingham 15
University of Birmingham, Key Competitors 16
University of Birmingham, Key Employees 17
University of Birmingham, Subsidiaries 18
University of Birmingham, Joint Venture 19

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ University of Birmingham-製薬・医療分野:企業M&A・提携分析(University of Birmingham - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆